{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T07:16:33Z","timestamp":1788419793052,"version":"build-2803163510"},"reference-count":172,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T00:00:00Z","timestamp":1788393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Endocrine therapy has improved the prognosis of patients with hormone receptor-positive (HR\n                    <jats:sup>+<\/jats:sup>\n                    ) breast cancer. However, acquired resistance remains a major cause of recurrence and progression, and the limited response of this subtype to immunotherapy highlights the need to better understand the mechanisms underlying immune escape. Recent studies indicate that, in addition to an immunosuppressive microenvironment, alterations in antigen processing and presentation may also contribute to immune escape, although systematic integration of these mechanisms remains lacking. Lipid metabolic reprogramming, as a key feature of tumor metabolic remodeling, supports tumor cell survival and adaptive evolution in endocrine-resistant HR\n                    <jats:sup>+<\/jats:sup>\n                    breast cancer and may also regulate antitumor immune responses through multilevel mechanisms. At the tumor cell level, enhanced fatty acid oxidation, increased lipid synthesis, and altered cholesterol metabolism may affect tumor immune visibility by influencing antigen presentation-related processes, including MHC class I-associated pathways. Within the immune microenvironment, lipid accumulation may contribute to dendritic cell dysfunction and promote the polarization of tumor-associated macrophages toward immunosuppressive phenotypes, thereby impairing antigen presentation. Consequently, persistent and inefficient antigen stimulation may promote T-cell dysfunction and exhaustion. This article systematically integrates the role of lipid metabolism in antigen presentation and T-cell regulation, and proposes a dysfunctional multilevel mechanistic axis of \u201clipid metabolism-antigen presentation-T-cell function\u201c, providing a theoretical basis for understanding immune evasion associated with endocrine resistance and for developing combination therapeutic strategies.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2026.1911296","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:42:33Z","timestamp":1788417753000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Immune evasion driven by lipid metabolic reprogramming in endocrine-resistant HR+ breast cancer: antigen presentation defects and T-cell dysfunction"],"prefix":"10.3389","volume":"17","author":[{"given":"Lutian","family":"Gong","sequence":"first","affiliation":[{"name":"Department of Oncology, China Academy of Chinese Medical Sciences Guang\u2019anmen Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujing","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Oncology, China Academy of Chinese Medical Sciences Guang\u2019anmen Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minglu","family":"Che","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangyang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing University of Chinese Medicine","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongni","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Oncology, China Academy of Chinese Medical Sciences Guang\u2019anmen Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenping","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Oncology, China Academy of Chinese Medical Sciences Guang\u2019anmen Hospital","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.01160","article-title":"Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: ASCO clinical practice guideline focused update","volume":"37","author":"Burstein","year":"2019","journal-title":"J Clin Oncol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-023-01393-6","article-title":"Advances in endocrine therapy for hormone receptor-positive advanced breast cancer","volume":"25","author":"Ziyeh","year":"2023","journal-title":"Curr Oncol Rep"},{"key":"B3","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ccell.2020.03.009","article-title":"Overcoming endocrine resistance in breast cancer","volume":"37","author":"Hanker","year":"2020","journal-title":"Cancer Cell"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000000923","article-title":"Endocrine therapy combined with targeted therapy in hormone receptor-positive metastatic breast cancer","volume":"133","author":"Bian","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.4149\/neo_2014_013","article-title":"Cellular and humoral immunodeficiency in breast cancer patients resistant to hormone therapy","volume":"61","author":"Zavadova","year":"2014","journal-title":"Neoplasma"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2018.7147","article-title":"Current landscape of immunotherapy in breast cancer: a review","volume":"5","author":"Adams","year":"2019","journal-title":"JAMA Oncol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/s41568-021-00339-z","article-title":"Antigen presentation in cancer: insights into tumour immunogenicity and immune evasion","volume":"21","author":"Jhunjhunwala","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B8","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1111\/imm.12675","article-title":"Antigen processing and immune regulation in the response to tumours","volume":"150","author":"Reeves","year":"2017","journal-title":"Immunology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1186\/s12885-018-4757-z","article-title":"Association of tamoxifen resistance and lipid reprogramming in breast cancer","volume":"18","author":"Hultsch","year":"2018","journal-title":"BMC Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000035048","article-title":"Correlation between serum lipid levels and endocrine resistance in patients with ER-positive breast cancer","volume":"102","author":"Sun","year":"2023","journal-title":"Med (Baltimore)"},{"key":"B11","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13045-021-01200-4","article-title":"Contradictory roles of lipid metabolism in immune response within the tumor microenvironment","volume":"14","author":"Yu","year":"2021","journal-title":"J Hematol Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201910698","article-title":"Lipid droplet-dependent fatty acid metabolism controls the immune suppressive phenotype of tumor-associated macrophages","volume":"11","author":"Wu","year":"2019","journal-title":"EMBO Mol Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"587","DOI":"10.3724\/abbs.2023068","article-title":"Ginsenoside Rh3 induces pyroptosis and ferroptosis through the Stat3\/p53\/NRF2 axis in colorectal cancer cells","volume":"55","author":"Wu","year":"2023","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/6177553","article-title":"Ginsenoside Rh4 inhibits colorectal cancer cell proliferation by inducing ferroptosis via autophagy activation","volume":"2022","author":"Wu","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1261283","article-title":"The role of the tumor\u00a0microenvironment in endocrine therapy resistance in hormone receptor-positive breast cancer","volume":"14","author":"Yuan","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2018.03.012","article-title":"T cell dysfunction in cancer","volume":"33","author":"Thommen","year":"2018","journal-title":"Cancer Cell"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2012.12.003","article-title":"T cell anergy, exhaustion, senescence, and stemness in the tumor microenvironment","volume":"25","author":"Crespo","year":"2013","journal-title":"Curr Opin Immunol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/bs.acr.2019.03.006","article-title":"Immunotherapy in breast cancer: current status and future directions","volume":"143","author":"Basu","year":"2019","journal-title":"Adv Cancer Res"},{"key":"B20","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1146\/annurev-biochem-061009-102430","article-title":"Lipid droplets and cellular lipid metabolism","volume":"81","author":"Walther","year":"2012","journal-title":"Annu Rev Biochem"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a040576","article-title":"Lipid metabolism","volume":"13","author":"Chandel","year":"2021","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/s43556-026-00427-2","article-title":"Metabolic reprogramming in cancer: dysregulation of glucose, lipid, and amino acid pathways and therapeutic opportunities","volume":"7","author":"Yu","year":"2026","journal-title":"Mol BioMed"},{"key":"B23","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12943-026-02582-0","article-title":"Metabolic reprogramming in cancer: signaling pathways and therapeutic targets","volume":"25","author":"Dong","year":"2026","journal-title":"Mol Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms242417422","article-title":"The role of tumor metabolic reprogramming in tumor immunity","volume":"24","author":"Zhang","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s13045-023-01498-2","article-title":"Lipid metabolic reprogramming in tumor microenvironment: from mechanisms to therapeutics","volume":"16","author":"Jin","year":"2023","journal-title":"J Hematol Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13081895","article-title":"Lipid metabolism reprogramming in cancer: insights into tumor cells and immune cells within the tumor microenvironment","volume":"13","author":"Liu","year":"2025","journal-title":"Biomedicines"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-026-01411-0","article-title":"Lipid metabolism reprogramming shapes the immune landscape in the tumor microenvironment","volume":"23","author":"Du","year":"2026","journal-title":"Cell Mol Immunol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.3c00382","article-title":"Tumor lipid signatures are descriptive of acquisition of therapy resistance in an endocrine-related breast cancer mouse model","volume":"23","author":"Ara\u00fajo","year":"2024","journal-title":"J Proteome Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2147\/BCTT.S575419","article-title":"Lipid metabolism and breast cancer therapy: an integrative literature review","volume":"18","author":"Gong","year":"2026","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1186\/s40170-020-00237-2","article-title":"The diversity and breadth of cancer cell fatty acid metabolism","volume":"9","author":"Nagarajan","year":"2012","journal-title":"Cancer Metab"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4331\/wjbc.v3.i8.167","article-title":"Dysregulated lipid metabolism in cancer","volume":"3","author":"Zhang","year":"2012","journal-title":"World J Biol Chem"},{"key":"B32","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12943-025-02258-1","article-title":"Lipid metabolic reprograming: the unsung hero in breast cancer progression and tumor microenvironment","volume":"24","author":"Wan","year":"2025","journal-title":"Mol Cancer"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2013.03.011","article-title":"Lipid biology of breast cancer","volume":"1831","author":"Baumann","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.2059","article-title":"Chemical inhibition of acetyl-CoA carboxylase suppresses self-renewal growth of cancer stem cells","volume":"5","author":"Corominas-Faja","year":"2014","journal-title":"Oncotarget"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2019.12.010","article-title":"ATP citrate lyase: a central metabolic enzyme in cancer","volume":"471","author":"Icard","year":"2020","journal-title":"Cancer Lett"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3892\/or.2017.5864","article-title":"Exogenous lipids promote the growth of breast cancer cells via CD36","volume":"38","author":"Zhao","year":"2017","journal-title":"Oncol Rep"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1186\/s12944-025-02833-x","article-title":"FABP4 in lipid metabolism and the tumor microenvironment: mechanisms and therapeutic potential","volume":"25","author":"Wang","year":"2025","journal-title":"Lipids Health Dis"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/imm.70045","article-title":"Molecular mediators of metabolic reprogramming in cancer: mechanisms, regulatory networks, and therapeutic strategies","volume":"177","author":"Ahuja","year":"2026","journal-title":"Immunology"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.7150\/ijbs.105361","article-title":"Fatty acid trafficking between lipid droplets and mitochondria: an emerging perspective","volume":"21","author":"Smolkov\u00e1","year":"2025","journal-title":"Int J Biol Sci"},{"key":"B40","article-title":"Lipid droplet and its implication in cancer progression","volume":"10","author":"Li","year":"2020","journal-title":"Am J Cancer Res"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-024-03054-9","article-title":"A prismatic view of the epigenetic-metabolic regulatory axis in breast cancer therapy resistance","volume":"43","author":"Das","year":"2024","journal-title":"Oncogene"},{"key":"B42","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13058-025-01991-1","article-title":"Lipid metabolic reprogramming drives triglyceride storage and variable sensitivity to FASN inhibition in endocrine-resistant breast cancer cells","volume":"27","author":"Ward","year":"2025","journal-title":"Breast Cancer Res"},{"key":"B43","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1158\/0008-5472.CAN-23-0184","article-title":"Metabolomic rewiring promotes endocrine therapy resistance in breast cancer","volume":"84","author":"Ahn","year":"2024","journal-title":"Cancer Res"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2024.122763","article-title":"Low GPR81 in ER+ breast cancer cells drives tamoxifen resistance through inducing PPAR\u03b1-mediated fatty acid oxidation","volume":"350","author":"Yu","year":"2024","journal-title":"Life Sci"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-24-1204","article-title":"Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy-tolerant persister cells in ER+ breast cancer","volume":"85","author":"Tau","year":"2025","journal-title":"Cancer Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/cells9122644","article-title":"Hormone receptor loss in breast cancer: molecular mechanisms, clinical settings, and therapeutic implications","volume":"9","author":"Zattarin","year":"2020","journal-title":"Cells"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-33602-7_9","article-title":"Mechanisms of endocrine resistance in hormone receptor-positive breast cancer","volume":"188","author":"Marra","year":"2023","journal-title":"Cancer Treat Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.6038","article-title":"Endocrine-sensitive disease rate in postmenopausal patients with estrogen receptor-rich\/ERBB2-negative breast cancer receiving neoadjuvant anastrozole, fulvestrant, or their combination: a phase 3 randomized clinical trial","volume":"10","author":"Ma","year":"2024","journal-title":"JAMA Oncol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2025.102407","article-title":"Molecular characterisation of the residual disease after neoadjuvant endocrine therapy in ER+\/HER2-breast cancer uncovers biomarkers of tumour response","volume":"57","author":"L\u00f3pez-Velazco","year":"2025","journal-title":"Transl Oncol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"3840","DOI":"10.1038\/s41467-019-11721-9","article-title":"Single-cell transcriptomics reveals multi-step adaptations to endocrine therapy","volume":"10","author":"Hong","year":"2019","journal-title":"Nat Commun"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2018.11.004","article-title":"Dormant, quiescent, tolerant and persister cells: four synonyms for the same target in cancer","volume":"162","author":"Vallette","year":"2019","journal-title":"Biochem Pharmacol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"4975","DOI":"10.1038\/s41467-022-32523-6","article-title":"Epithelial-mesenchymal plasticity determines estrogen receptor positive breast cancer dormancy and epithelial reconversion drives recurrence","volume":"13","author":"Aouad","year":"2022","journal-title":"Nat Commun"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3390\/cancers16162906","article-title":"Elevated GRHL2 imparts plasticity in ER-positive breast cancer cells","volume":"16","author":"Zheng","year":"2024","journal-title":"Cancers (Basel)"},{"key":"B54","doi-asserted-by":"publisher","first-page":"4221","DOI":"10.1038\/s41467-023-40022-5","article-title":"Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancers","volume":"14","author":"El-Botty","year":"2023","journal-title":"Nat Commun"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-024-00898-8","article-title":"ER\u03b1 dysfunction caused by ESR1 mutations and therapeutic pressure promotes lineage plasticity in ER+ breast cancer","volume":"6","author":"Liang","year":"2025","journal-title":"Nat Cancer"},{"key":"B56","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/s41419-023-06181-5","article-title":"Targeting c-Jun inhibits fatty acid oxidation to overcome tamoxifen resistance in estrogen receptor-positive breast cancer","volume":"14","author":"Jiang","year":"2023","journal-title":"Cell Death Dis"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1093\/jmcb\/mjab018","article-title":"Fatty acid oxidation and autophagy promote endoxifen resistance and counter the effect of AKT inhibition in ER-positive breast cancer cells","volume":"13","author":"Duan","year":"2021","journal-title":"J Mol Cell Biol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1105117","article-title":"FDXR drives primary and endocrine-resistant tumor cell growth in ER+ breast cancer via CPT1A-mediated fatty acid oxidation","volume":"13","author":"Yan","year":"2023","journal-title":"Front Oncol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41417-023-00683-2","article-title":"Tafazzin mediates tamoxifen resistance by regulating cellular phospholipid composition in ER-positive breast cancer","volume":"31","author":"Li","year":"2024","journal-title":"Cancer Gene Ther"},{"key":"B60","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s10565-025-10068-w","article-title":"ZMIZ1 lactylation induces tamoxifen resistance in breast cancer through increasing transcriptional activity of Nanog to impact cell stemness and cholesterol uptake","volume":"41","author":"Liu","year":"2025","journal-title":"Cell Biol Toxicol"},{"key":"B61","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3892\/ijo.2025.5806","article-title":"Adipocyte-derived extracellular vesicles sustain mitochondrial metabolism in breast cancer cells: New insights into the cross-talk between cancer cells and the tumor microenvironment","volume":"67","author":"Gelsomino","year":"2025","journal-title":"Int J Oncol"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-022-06794-y","article-title":"Obesity and metabolic syndrome are associated with short-term endocrine therapy resistance in early ER+ breast cancer","volume":"197","author":"Bergman","year":"2023","journal-title":"Breast Cancer Res Treat"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21207661","article-title":"Fatty acid synthase is a key enabler for endocrine resistance in heregulin-overexpressing luminal B-like breast cancer","volume":"21","author":"Menendez","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17040650","article-title":"Lipid metabolism in breast cancer: From basic research to clinical application","volume":"17","author":"Huang","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2025.152200","article-title":"AP1S3 affects lipid metabolism in breast cancer cells by regulating the PI3K\/AKT\/mTOR pathway","volume":"776","author":"Wu","year":"2025","journal-title":"Biochem Biophys Res Commun"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3390\/biology9120474","article-title":"Lipid metabolism and resistance to anticancer treatment","volume":"9","author":"Germain","year":"2020","journal-title":"Biol (Basel)"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13112605","article-title":"Cholesterol-induced metabolic reprogramming in breast cancer cells is mediated via the ERR\u03b1 pathway","volume":"13","author":"Ghanbari","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-016-0713-5","article-title":"Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer","volume":"18","author":"Simigdala","year":"2016","journal-title":"Breast Cancer Res"},{"key":"B69","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1007\/s11684-020-0793-6","article-title":"Metabolism and immunity in breast cancer","volume":"15","author":"Zhang","year":"2021","journal-title":"Front Med"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.3892\/or.2021.7946","article-title":"Metabolic heterogeneity and immunocompetence of infiltrating immune cells in the breast cancer microenvironment (Review)","volume":"45","author":"Chen","year":"2021","journal-title":"Oncol Rep"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8798","article-title":"Differential expression of major histocompatibility complex class I in subtypes of breast cancer is associated with estrogen receptor and interferon signaling","volume":"7","author":"Lee","year":"2016","journal-title":"Oncotarget"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.13083","article-title":"Prolonged estrogen deprivation triggers a broad immunosuppressive phenotype in breast cancer cells","volume":"16","author":"H\u00fchn","year":"2022","journal-title":"Mol Oncol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1038\/s44321-025-00213-7","article-title":"MHC-I upregulation by macbecin II in the solid tumors potentiates the effect of active immunotherapy","volume":"17","author":"Deshpande","year":"2025","journal-title":"EMBO Mol Med"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140837","article-title":"MAL2 drives immune evasion in breast cancer by suppressing tumor antigen presentation","volume":"131","author":"Fang","year":"2021","journal-title":"J Clin Invest"},{"key":"B75","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13046-019-1040-3","article-title":"Aberrant fatty acid profile and FFAR4 signaling confer endocrine resistance in breast cancer","volume":"38","author":"Chu","year":"2019","journal-title":"J Exp Clin Cancer Res"},{"key":"B76","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13058-018-1041-8","article-title":"Key regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancer","volume":"20","author":"Du","year":"2018","journal-title":"Breast Cancer Res"},{"key":"B77","doi-asserted-by":"publisher","first-page":"7035","DOI":"10.1038\/s41467-025-62134-w","article-title":"Mogat1 drives metabolic adaptations to evade immune surveillance","volume":"16","author":"Wei","year":"2025","journal-title":"Nat Commun"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2022.10.027","article-title":"The impact of lipids on the cancer-immunity cycle and strategies for modulating lipid metabolism to improve cancer immunotherapy","volume":"13","author":"Zheng","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.039727","article-title":"Endocytosis of MHC molecules by distinct membrane rafts","volume":"122","author":"Knorr","year":"2009","journal-title":"J Cell Sci"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3945\/jn.109.108720","article-title":"Docosahexaenoic acid modifies the clustering and size of lipid rafts and the lateral organization and surface expression of MHC class I of EL4 cells","volume":"139","author":"Shaikh","year":"2009","journal-title":"J Nutr"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1111\/1750-3841.15900","article-title":"Docosahexaenoic acid monoglyceride induces apoptosis and autophagy in breast cancer cells via lipid peroxidation-mediated endoplasmic reticulum stress","volume":"86","author":"Wang","year":"2021","journal-title":"J Food Sci"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2172-10-10","article-title":"ER stress affects processing of MHC class I-associated peptides","volume":"10","author":"Granados","year":"2009","journal-title":"BMC Immunol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.16255","article-title":"Regulation of lipid metabolism by the unfolded protein response","volume":"25","author":"Moncan","year":"2021","journal-title":"J Cell Mol Med"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1172\/JCI193153","article-title":"Estrogen receptor signaling drives immune evasion and immunotherapy resistance in HR+ breast cancer","volume":"136","author":"Palomeque","year":"2025","journal-title":"J Clin Invest"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2017.91","article-title":"SREBP-regulated lipid metabolism: convergent physiology-divergent pathophysiology","volume":"13","author":"Shimano","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-2616","article-title":"Endoplasmic reticulum stress protein GRP78 modulates lipid metabolism to control drug sensitivity and antitumor immunity in breast cancer","volume":"76","author":"Cook","year":"2016","journal-title":"Cancer Res"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2024.101376","article-title":"Lipid metabolism involved in progression and drug resistance of breast cancer","volume":"12","author":"Fu","year":"2024","journal-title":"Genes Dis"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.31083\/j.fbl2812348","article-title":"Fatty acid metabolism: A new perspective in breast cancer precision therapy","volume":"28","author":"He","year":"2023","journal-title":"Front Biosci (Landmark Ed)"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.89","article-title":"The multifaceted roles of fatty acid synthesis in cancer","volume":"16","author":"R\u00f6hrig","year":"2016","journal-title":"Nat Rev Cancer"},{"key":"B90","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12964-023-01178-1","article-title":"The impact of lipid metabolism on breast cancer: a review about its role in tumorigenesis and immune escape","volume":"21","author":"Zipinotti Dos Santos","year":"2023","journal-title":"Cell Commun Signal"},{"key":"B91","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12943-021-01486-5","article-title":"Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy","volume":"21","author":"Lian","year":"2022","journal-title":"Mol Cancer"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.138581","article-title":"Polymorphonuclear myeloid-derived suppressor cells limit antigen cross-presentation by dendritic cells in cancer","volume":"5","author":"Ugolini","year":"2020","journal-title":"JCI Insight"},{"key":"B93","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1038\/s42003-025-07977-1","article-title":"Targeting SCD triggers lipotoxicity of cancer cells and enhances anti-tumor immunity in breast cancer brain metastasis mouse models","volume":"8","author":"Sammarco","year":"2025","journal-title":"Commun Biol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2172","article-title":"Lipid accumulation and dendritic cell dysfunction in cancer","volume":"16","author":"Herber","year":"2010","journal-title":"Nat Med"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.05.025","article-title":"ER stress sensor XBP1 controls anti-tumor immunity by disrupting dendritic cell homeostasis","volume":"161","author":"Cubillos-Ruiz","year":"2015","journal-title":"Cell"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0123563","article-title":"Mesothelioma tumor cells modulate dendritic cell lipid content, phenotype and function","volume":"10","author":"Gardner","year":"2015","journal-title":"PloS One"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.108278","article-title":"PPAR\u03b1 inhibition overcomes tumor-derived exosomal lipid-induced dendritic cell dysfunction","volume":"33","author":"Yin","year":"2020","journal-title":"Cell Rep"},{"key":"B98","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1038\/s41467-017-02186-9","article-title":"Lipid bodies containing oxidatively truncated lipids block antigen cross-presentation by dendritic cells in cancer","volume":"8","author":"Veglia","year":"2017","journal-title":"Nat Commun"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1302801","article-title":"Oxidized lipids block antigen cross-presentation by dendritic cells in cancer","volume":"192","author":"Ramakrishnan","year":"2014","journal-title":"J Immunol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5708239","article-title":"Lipid accumulation in peripheral blood dendritic cells and anticancer immunity in patients with lung cancer","volume":"2018","author":"Arai","year":"2018","journal-title":"J Immunol Res"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2025.1548724","article-title":"Intercellular communication between extracellular vesicles from conditioned macrophages and breast cancer cells drives endocrine therapy resistance","volume":"13","author":"Rodriguez-Baili","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-17-2465","article-title":"Expression of adipocyte\/macrophage fatty acid-binding protein in tumor-associated macrophages promotes breast cancer progression","volume":"78","author":"Hao","year":"2018","journal-title":"Cancer Res"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2022.2085432","article-title":"Lipid-associated macrophages in the tumor-adipose microenvironment facilitate breast cancer progression","volume":"11","author":"Liu","year":"2022","journal-title":"Oncoimmunology"},{"key":"B104","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13578-022-00823-5","article-title":"Targeting tumor-associated macrophages for cancer treatment","volume":"12","author":"Li","year":"2022","journal-title":"Cell Biosci"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/imm.70103","article-title":"Bidirectional regulation in the tumour microenvironment: The interaction between tumour-associated macrophages and T cells reshapes the paradigm of cancer immunotherapy","volume":"178","author":"Li","year":"2026","journal-title":"Immunology"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2014.09.006","article-title":"Macrophage IL-10 blocks CD8+ T cell-dependent responses to chemotherapy by suppressing IL-12 expression in intratumoral dendritic cells","volume":"26","author":"Ruffell","year":"2014","journal-title":"Cancer Cell"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-014-0352-6","article-title":"Increased drug resistance in breast cancer by tumor-associated macrophages through IL-10\/STAT3\/bcl-2 signaling pathway","volume":"32","author":"Yang","year":"2015","journal-title":"Med Oncol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-4672","article-title":"Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes","volume":"70","author":"Movahedi","year":"2010","journal-title":"Cancer Res"},{"key":"B109","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/s41467-024-45084-7","article-title":"Neutral ceramidase regulates breast cancer progression by metabolic programming of TREM2-associated macrophages","volume":"15","author":"Sun","year":"2024","journal-title":"Nat Commun"},{"key":"B110","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.immuni.2024.11.026","article-title":"Antigen presentation by tumor-associated macrophages drives T cells from a progenitor exhaustion state to terminal exhaustion","volume":"58","author":"Waibl Polania","year":"2025","journal-title":"Immunity"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-024-01224-z","article-title":"Regulation of CD8+ T cells by lipid metabolism in cancer progression","volume":"21","author":"Tang","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010179","article-title":"Progesterone receptor-dependent downregulation of MHC class I promotes tumor immune evasion and growth in breast cancer","volume":"13","author":"Tinoco","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B113","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.immuni.2022.12.002","article-title":"CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor","volume":"56","author":"Prokhnevska","year":"2023","journal-title":"Immunity"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-023-00527-w","article-title":"Immune landscape in invasive ductal and lobular breast cancer reveals a divergent macrophage-driven microenvironment","volume":"4","author":"Onkar","year":"2023","journal-title":"Nat Cancer"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.6425","article-title":"The immune microenvironment characterisation and dynamics in hormone receptor-positive breast cancer before and after neoadjuvant endocrine therapy","volume":"12","author":"Oner","year":"2023","journal-title":"Cancer Med"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202551771","article-title":"Treg control of CD80\/CD86 expression mediates immune system homeostasis","volume":"55","author":"Kim","year":"2025","journal-title":"Eur J Immunol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s12964-022-00849-9","article-title":"The activation of PPAR\u03b3 enhances Treg responses through up-regulating CD36\/CPT1-mediated fatty acid oxidation and subsequent N-glycan branching of T\u03b2RII\/IL-2R\u03b1","volume":"20","author":"Miao","year":"2022","journal-title":"Cell Commun Signal"},{"key":"B118","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1111\/imm.13887","article-title":"FOXP3 transcriptionally activates fatty acid scavenger receptor CD36 in tumour-induced Treg cells","volume":"174","author":"Dhar","year":"2025","journal-title":"Immunology"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-2360","article-title":"Regulatory T cells recruited through CCL22\/CCR4 are selectively activated in lymphoid infiltrates surrounding primary breast tumors and lead to an adverse clinical outcome","volume":"69","author":"Gobert","year":"2009","journal-title":"Cancer Res"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2023739118","article-title":"Treg-expressed CTLA-4 depletes CD80\/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells","volume":"118","author":"Tekguc","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14626","article-title":"CTLA-4 positive breast cancer cells suppress dendritic cells maturation and function","volume":"8","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e37699","article-title":"Boosting immunotherapy efficacy: Empowering the potency of dendritic cells loaded with breast cancer lysates through CTLA-4 suppression","volume":"10","author":"Bakhshivand","year":"2024","journal-title":"Heliyon"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2016.12.008","article-title":"Tumor-derived CD4+CD25+regulatory T cells inhibit dendritic cells function by CTLA-4","volume":"213","author":"Chen","year":"2017","journal-title":"Pathol Res Pract"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1728354","article-title":"Lipid metabolic reprogramming in the tumor microenvironment and its mechanistic role in immunosuppressive cells","volume":"16","author":"Liu","year":"2025","journal-title":"Front Immunol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/s41467-022-35238-w","article-title":"A comprehensive single-cell map of T cell exhaustion-associated immune environments in human breast cancer","volume":"14","author":"Tietscher","year":"2023","journal-title":"Nat Commun"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2025.2502354","article-title":"CD8+ T cells in breast cancer tumors and draining lymph nodes: PD-1 levels, effector functions and prognostic relevance","volume":"14","author":"Abrate","year":"2025","journal-title":"Oncoimmunology"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-023-01578-y","article-title":"Hallmarks of CD8+ T cell dysfunction are established within hours of tumor antigen encounter before cell division","volume":"24","author":"Rudloff","year":"2023","journal-title":"Nat Immunol"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-024-01843-8","article-title":"Antitumor progenitor exhausted CD8+ T cells are sustained by TCR engagement","volume":"25","author":"Lan","year":"2024","journal-title":"Nat Immunol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41419-024-06721-7","article-title":"The cell cycle regulator p16 promotes tumor infiltrated CD8+ T cell exhaustion and apoptosis","volume":"15","author":"Zhang","year":"2024","journal-title":"Cell Death Dis"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-006019","article-title":"Dendritic cell therapy augments antitumor immunity triggered by CDK4\/6 inhibition and immune checkpoint blockade by unleashing systemic CD4 T-cell responses","volume":"11","author":"Kumar","year":"2023","journal-title":"J Immunother Cancer"},{"key":"B131","doi-asserted-by":"publisher","first-page":"2044","DOI":"10.1016\/j.immuni.2022.10.002","article-title":"Tumor-associated macrophages expressing the transcription factor IRF8 promote T cell exhaustion in cancer","volume":"55","author":"Nixon","year":"2022","journal-title":"Immunity"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-024-00775-4","article-title":"Tumor-associated macrophages restrict CD8+ T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment","volume":"5","author":"Tharp","year":"2024","journal-title":"Nat Cancer"},{"key":"B133","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1016\/j.immuni.2024.08.003","article-title":"PD-1 signaling limits expression of phospholipid phosphatase 1 and promotes intratumoral CD8+ T cell ferroptosis","volume":"57","author":"Ping","year":"2024","journal-title":"Immunity"},{"key":"B134","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.cmet.2024.02.009","article-title":"Acetyl-CoA carboxylase obstructs CD8+ T cell lipid utilization in the tumor microenvironment","volume":"36","author":"Hunt","year":"2024","journal-title":"Cell Metab"},{"key":"B135","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12943-024-02165-x","article-title":"Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer","volume":"23","author":"Liu","year":"2024","journal-title":"Mol Cancer"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1381970","article-title":"Targeting metabolism of breast cancer and its implications in T cell immunotherapy","volume":"15","author":"Zou","year":"2024","journal-title":"Front Immunol"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2024.101960","article-title":"Resonance of fatty acid metabolism and immune infiltration in anti-PD-1 monotherapy for breast cancer","volume":"44","author":"Zhao","year":"2024","journal-title":"Transl Oncol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2025.118682","article-title":"Circular RNAs as central regulators of metabolic reprogramming and immune responses in the breast cancer microenvironment: A comprehensive review","volume":"193","author":"Sherafat","year":"2025","journal-title":"BioMed Pharmacother"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2026.1748257","article-title":"Targeting the tripartite axis of immune-metabolic-spatial crosstalk to overcome therapy resistance in breast cancer","volume":"17","author":"He","year":"2026","journal-title":"Front Immunol"},{"key":"B140","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/s41420-024-02184-z","article-title":"Fatty acid synthase (FASN) is a tumor-cell-intrinsic metabolic checkpoint restricting T-cell immunity","volume":"10","author":"Cuy\u00e0s","year":"2024","journal-title":"Cell Death Discov"},{"key":"B141","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s13046-025-03548-8","article-title":"FASN inhibits ferroptosis in breast cancer via USP5 palmitoylation-dependent regulation of GPX4 deubiquitination","volume":"44","author":"Qian","year":"2025","journal-title":"J Exp Clin Cancer Res"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1256747","article-title":"Impact of statin use on breast cancer recurrence and mortality before and after diagnosis: a systematic review and meta-analysis","volume":"13","author":"Jia","year":"2023","journal-title":"Front Oncol"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2024.102573","article-title":"Post-surgery statin use contributes to favorable outcomes in patients with early breast cancer","volume":"90","author":"Giorello","year":"2024","journal-title":"Cancer Epidemiol"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14081660","article-title":"Atorvastatin enhances the efficacy of immune checkpoint therapy and suppresses the cellular and extracellular vesicle PD-L1","volume":"14","author":"Choe","year":"2022","journal-title":"Pharmaceutics"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000001582","article-title":"Statins inhibit paclitaxel-induced PD-L1 expression and increase CD8+ T cytotoxicity for better prognosis in breast cancer","volume":"110","author":"Li","year":"2024","journal-title":"Int J Surg"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2020.05.034","article-title":"Targeting metabolism to improve the tumor microenvironment for cancer immunotherapy","volume":"78","author":"Bader","year":"2020","journal-title":"Mol Cell"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17172940","article-title":"Unlocking the potential of immune checkpoint inhibitors in HR+\/HER2- breast cancer: a systematic review","volume":"17","author":"Di Grazia","year":"2025","journal-title":"Cancers (Basel)"},{"key":"B148","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"key":"B149","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41523-025-00742-x","article-title":"A pilot study incorporating HER2-directed dendritic cells into neoadjuvant therapy of early stage HER2+ER- breast cancer","volume":"11","author":"Soliman","year":"2025","journal-title":"NPJ Breast Cancer"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2024.5371","article-title":"Alteration of the tumor microenvironment with intratumoral dendritic cells before chemotherapy in ERBB2 breast cancer: a nonrandomized clinical trial","volume":"11","author":"Han","year":"2025","journal-title":"JAMA Oncol"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-22-3578","article-title":"A phase I\/II trial of HER2 vaccine-primed autologous T-cell infusions in patients with treatment refractory HER2-overexpressing breast cancer","volume":"29","author":"Disis","year":"2023","journal-title":"Clin Cancer Res"},{"key":"B152","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13045-025-01661-x","article-title":"WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, Malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome","volume":"18","author":"Berneman","year":"2025","journal-title":"J Hematol Oncol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.adj3945","article-title":"STING licensing of type I dendritic cells potentiates antitumor immunity","volume":"9","author":"Wang","year":"2024","journal-title":"Sci Immunol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1485546","article-title":"Clinical applications of STING agonists in cancer immunotherapy: current progress and future prospects","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14174279","article-title":"Phase II study combining pembrolizumab with aromatase inhibitor in patients with metastatic hormone receptor positive breast cancer","volume":"14","author":"Ge","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101879","article-title":"Hormone therapy enhances anti-PD1 efficacy in premenopausal estrogen receptor-positive and HER2-negative advanced breast cancer","volume":"6","author":"Chen","year":"2025","journal-title":"Cell Rep Med"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03414-8","article-title":"Neoadjuvant nivolumab and chemotherapy in early estrogen receptor-positive breast cancer: a randomized phase 3 trial","volume":"31","author":"Loi","year":"2025","journal-title":"Nat Med"},{"key":"B158","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/s41523-022-00482-2","article-title":"Abemaciclib in combination with pembrolizumab for HR+, HER2- metastatic breast cancer: Phase 1b study","volume":"8","author":"Rugo","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1038\/s43018-024-00729-w","article-title":"Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial","volume":"5","author":"Roussos Torres","year":"2024","journal-title":"Nat Cancer"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2025.217823","article-title":"Therapeutic targeting of circTNK2 with nanoparticles restores tamoxifen sensitivity and enhances NK cell-mediated immunity in ER-positive breast cancer","volume":"627","author":"Wu","year":"2025","journal-title":"Cancer Lett"},{"key":"B161","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/ijc.70421","article-title":"Reprogramming innate immunity to overcome endocrine resistance in estrogen receptor-positive breast cancer","volume":"159","author":"Muhammad","year":"2026","journal-title":"Int J Cancer"},{"key":"B162","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1186\/s12967-024-05517-9","article-title":"Inverse FASN and LDHA correlation drives metabolic resistance in breast cancer","volume":"22","author":"Papulino","year":"2024","journal-title":"J Transl Med"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jproteome.5c00669","article-title":"Metabolic-immuno-hormonal cross-talk in breast cancer: a UAE-based multi-omics perspective","volume":"25","author":"Shakartalla","year":"2026","journal-title":"J Proteome Res"},{"key":"B164","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-025-00873-1","article-title":"Biomarker prediction of immunotherapy response in breast cancer: from single markers to multi-omics integration","volume":"12","author":"Sanjari Moghaddam","year":"2025","journal-title":"NPJ Breast Cancer"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1172\/JCI183656","article-title":"MAP3K1 mutations confer tumor immune heterogeneity in hormone receptor-positive HER2-negative breast cancer","volume":"135","author":"Cai","year":"2024","journal-title":"J Clin Invest"},{"key":"B166","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s12920-025-02194-5","article-title":"A lipid metabolism-related gene signature predicts prognosis after tamoxifen treatment in ER+\u2009breast cancer and reflects tumor microenvironment heterogeneity through single-cell analysis","volume":"18","author":"Ma","year":"2025","journal-title":"BMC Med Genomics"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1007\/s13402-025-01081-6","article-title":"Lipid metabolism in cancer stem cells: reprogramming, mechanisms, crosstalk, and therapeutic approaches","volume":"48","author":"Lee","year":"2025","journal-title":"Cell Oncol (Dordr)"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2025.189396","article-title":"Metabolic reprogramming in breast cancer: pathways driving progression, drug resistance, and emerging therapeutics","volume":"1880","author":"Garg","year":"2025","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-25-1339","article-title":"ESR1-activating mutations confer metabolic vulnerabilities in ER+ breast cancer","volume":"86","author":"Bonechi","year":"2026","journal-title":"Cancer Res"},{"key":"B170","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1186\/s12885-022-10430-9","article-title":"Metabolic abnormalities and survival among patients with non-metastatic breast cancer","volume":"22","author":"Zimbalist","year":"2022","journal-title":"BMC Cancer"},{"key":"B171","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41540-025-00506-0","article-title":"A single-cell network approach to decode metabolic regulation in gynecologic and breast cancers","volume":"11","author":"Srivastava","year":"2025","journal-title":"NPJ Syst Biol Appl"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1470167","article-title":"Integration of transcriptomics and machine learning for insights into breast cancer: exploring lipid metabolism and immune interactions","volume":"15","author":"Chen","year":"2024","journal-title":"Front Immunol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1911296\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T06:42:35Z","timestamp":1788417755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1911296\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,3]]},"references-count":172,"alternative-id":["10.3389\/fimmu.2026.1911296"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1911296","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,3]]},"article-number":"1911296"}}